<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Investment Strategy on AI Survival Blog</title><link>http://localhost:1313/categories/investment-strategy/</link><description>Recent content in Investment Strategy on AI Survival Blog</description><generator>Hugo -- 0.155.3</generator><language>en-us</language><lastBuildDate>Sun, 15 Feb 2026 17:30:00 +0900</lastBuildDate><atom:link href="http://localhost:1313/categories/investment-strategy/index.xml" rel="self" type="application/rss+xml"/><item><title>How AI is Killing Biotech: The AbCellera Collapse Reveals a Brutal Truth (Part 1)</title><link>http://localhost:1313/posts/ai-kills-biotech-abcellera-analysis/</link><pubDate>Sun, 15 Feb 2026 17:30:00 +0900</pubDate><guid>http://localhost:1313/posts/ai-kills-biotech-abcellera-analysis/</guid><description>AbCellera&amp;#39;s 92.6% decline exposes the structural disruption reshaping biotech. Why AI antibody discovery platforms are becoming obsolete.</description></item></channel></rss>